medigraphic.com
ISSN 0210-5187 (Electronic)

2014, Number 4-6

<< Back Next >>

Med Cutan Iber Lat Am 2014; 42 (4-6)

Eumycetoma due to Madurella mycetomatis: first imported identified case in Spain

Valdés TF, Montero FLÁ, Serrano LM, Prieto RE

Language: Spanish
References: 11
Page: 129-132
PDF size: 404.60 Kb.


ABSTRACT

Eumycetoma is a located subcutaneous infectious disease caused by fungi. We report an imported case of eumycetoma in a 39-year-old woman natural of Cape Verde. Microbiological analysis revealed the organism to be Madurella mycetomatis. She presented a slow growing firm tumour on the dorsal aspect of her right foot for 30 years. Computerized axial tomography revealed osteomyelitis of her fourth metatarsal bone. She was successfully treated with surgical debridement, fluconazole and voriconazole.


REFERENCES

  1. Chávez G, Arenas R, Pérez-Polito A, Torres B, Estrada R. Micetomas eumicéticos por Madurella mycetomatis. Informe de seis casos. Rev Iberoam Micol. 1998; 15: 90-93.

  2. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health. 2002; 7: 788-792.

  3. Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004; 4: 566-574.

  4. de Hoog G, Guarro J, Gené J, Figueras M. Atlas of Clinical Fungi. 2ª ed. Utrech: Centraalbureau voor Schimmelcultures, 2000.

  5. Sharif HS, Clark DC, Aabed MY, Aideyan OA, Mattsson TA, Haddad MC et al. Mycetoma: comparison of MR imaging with CT. Radiology. 1991; 178: 865-870.

  6. van de Sande WW, Luijendijk A, Ahmed AO, Bakker-Woudenberg IA, van Belkum A. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother. 2005; 49: 1364-1368.

  7. Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chavin M. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol. 2005; 152: 1067-1068.

  8. van Belkum A, Fahal AH, van de Sande WW. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. Antimicrob Agents Chemother. 2011; 55: 1771-1773.

  9. Loulergue P, Hot A, Dannaoui E, Dallot A, Poirée S, Dupont B, Lortholary O. Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg. 2006; 75: 1106-1107.

  10. Verdolini R, Amerio P, Bugatti L, Manso E, Cataldi I, Brancorsini D et al. Madura’s foot: report of a case caused by Madurella mycetomatis. Eur J Dermatol. 2000; 10: 627-629.

  11. Ramos MA, Salas VI, Ramírez FC, Sánchez-Vegazo SI. Mujer de origen filipino con tumoración en un pie. Rev Clin Esp. 2007; 207: 305-306.




2020     |     www.medigraphic.com